CONMED
CNMD
252 hedge funds and large institutions have $4.3B invested in CONMED in 2021 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 95 increasing their positions, 78 reducing their positions, and 20 closing their positions.
80% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 20
22% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 78
6% more capital invested
Capital invested by funds: $4.05B → $4.3B (+$248M)
5% more funds holding
Funds holding: 239 → 252 (+13)
0.68% more ownership
Funds ownership: 107.28% → 107.96% (+0.68%)
93% less call options, than puts
Call options by funds: $1.95M | Put options by funds: $26.6M
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$59.8M |
| 2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$37.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$28.5M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$28M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$19.4M |
Top Sellers
| 1 |
CVA
Ceredex Value Advisors
Orlando,
Florida
|
-$42.5M |
| 2 |
HM
HealthCor Management
New York
|
-$36.2M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$31.3M |
| 4 |
Millennium Management
New York
|
-$25.3M |
| 5 |
BlackRock
New York
|
-$16.6M |
CNMD Hedge Fund Activity: Q2 2021 in Review
252 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2021, worth a combined $4.3B — up 6.1% from $4.05B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new CNMD positions and 20 closed out — a net gain of 16 holders — while 95 added to existing stakes and 78 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $59.8M. The largest seller was Ceredex Value Advisors, exiting entirely with an estimated $42.5M sold.
- 252 institutional investors held CONMED (CNMD) as of Q2 2021, up from 239 in Q1 2021.
- Funds reported $4.3B of CONMED stock for Q2 2021, up 6.1% quarter-over-quarter.
- 36 funds opened new CONMED positions in Q2 2021 and 20 closed out, a net change of +16 holders.
- The largest CONMED buyer in Q2 2021 was JP Morgan Chase, an estimated $59.8M added.
- The largest CONMED seller in Q2 2021 was Ceredex Value Advisors, an estimated $42.5M sold.
Based on aggregated 13F filings for Q2 2021.